XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 46.58

Change

-0.04 (-0.09)%

Market Cap

CAD 0.55B

Volume

4.58K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-31 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.18 (-0.12%)

CAD 21.68B
ZSP:CA BMO S&P 500

-0.10 (-0.10%)

CAD 19.55B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.31 (-0.49%)

CAD 12.06B
VUN:CA Vanguard US Total Market

-0.20 (-0.17%)

CAD 11.46B
XUS:CA iShares Core S&P 500 Index ETF

-0.06 (-0.11%)

CAD 8.74B
HXS:CA Global X S&P 500 Corporate Cla..

-0.14 (-0.16%)

CAD 4.79B
VSP:CA Vanguard S&P 500 CAD hedged

-0.45 (-0.46%)

CAD 4.16B
XUU:CA iShares Core S&P US Total Mark..

-0.06 (-0.09%)

CAD 3.50B
QUU:CA Mackenzie US Large Cap Equity ..

-0.11 (-0.04%)

CAD 3.48B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.08 (-0.15%)

CAD 3.42B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.72% 57% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.72% 55% F 68% D+
Trailing 12 Months  
Capital Gain 31.25% 80% B- 83% B
Dividend Return 1.04% 28% F 12% F
Total Return 32.29% 81% B- 82% B
Trailing 5 Years  
Capital Gain 100.52% 75% C 86% B+
Dividend Return 6.72% 15% F 11% F
Total Return 107.24% 72% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 15.18% 78% C+ 79% B-
Dividend Return 16.04% 75% C 76% C+
Total Return 0.86% 27% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.64% 37% F 54% F
Risk Adjusted Return 102.59% 64% D 95% A
Market Capitalization 0.55B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.